Results 11 to 20 of about 163,345 (226)

Differential Neural Dynamics in Psychomotor Retardation and Agitation of Depression. [PDF]

Hum Brain Mapp
Psychomotor disturbances like agitation and retardation are key symptoms of major depressive disorder (MDD). Despite their clinical significance, the underlying neural mechanisms, for example, motor or psychomotor, remain yet elusive. This study aimed to
Liang Q, Xu Z, Chen S, Lin S, Lin X, Li Y, Zhang Y, Peng B, Hou G, Qiu Y, Northoff G.   +10 more
europepmc   +5 more sources

Acute psychomotor agitation - challenges for psychiatrists and neurologists: a case study. [PDF]

Postep Psychiatr Neurol, 2022
Purpose Bilateral thalamic ischemia can, paradoxically, manifest itself with various non-sensory clinical symptoms, thereby complicating diagnosis. Case description A 59-year-old woman was admitted to an Emergency Department about and hour and a half ...
Luchowski P, Sojka M, Oleksak I, Jartych A, Piwoński M, Rejdak K.   +5 more
europepmc   +5 more sources

Study of Psychomotor Agitation Constraint Method: A Systematic Review. [PDF]

Actas Esp Psiquiatr
Background: Psychomotor agitation is a common psychiatric disorder that often requires physical restraint, consuming significant healthcare resources.
Zhu S, Liu J, Cao A, Jiang F, Wang R.
europepmc   +4 more sources

Brazilian guidelines for the management of psychomotor agitation. Part 2. Pharmacological approach. [PDF]

Braz J Psychiatry, 2019
Objective: To present the essential guidelines for pharmacological management of patients with psychomotor agitation in Brazil. Methods: This is a systematic review of articles retrieved from the MEDLINE (PubMed), Cochrane Database of Systematic Reviews,
Baldaçara L, Diaz AP, Leite V, Pereira LA, Dos Santos RM, Gomes Júnior VP, Calfat ELB, Ismael F, Périco CAM, Porto DM, Zacharias CEK, Cordeiro Q, da Silva AG, Tung TC.   +13 more
europepmc   +4 more sources

Psychomotor agitation and hyperactive delirium in COVID-19 patients treated with aripiprazole 9.75 mg/1.3 ml immediate release. [PDF]

Psychopharmacology (Berl), 2020
Delirium and psychomotor agitation are relevant clinical conditions that may develop during COVID-19 infection, especially in intensive care unit (ICU) settings, in patients with acute respiratory distress and in isolation environments (Qiu et al. 2020).
Martinotti G, Barlati S, Prestia D, Palumbo C, Giordani M, Cuomo A, Miuli A, Paladini C, Amore M, Bondi E, Vita A, Fagiolini A, Di Giannantonio M.   +12 more
europepmc   +4 more sources

Episodes of aggression and psychomotor agitation in psychiatric inpatients during the period of Covid-19 pandemia [PDF]

European Psychiatry, 2023
Introduction The COVID-19 pandemic has changed social, family, and interpersonal relationships and behaviors. Several studies have identified the increase in psychiatric disorders in the general population (Fountoulakis et al.
F. Franza, B. Solomita
doaj   +3 more sources

Psychomotor Agitation Non-responsive to Treatment: A Case Report of Phenibut Withdrawal Syndrome [PDF]

Frontiers in Psychiatry, 2021
Background and Objectives: Phenibut (4-amino-3-phenyl-butyric acid), acting as a GABA-B receptor agonist, has a beneficial effect on anxiety. Although its medical use is not approved in western countries, it can be easily obtained worldwide via the ...
Cecilia Maria Esposito, Gian Mario Mandolini, Giuseppe Delvecchio, Alessio Fiorentini, Paolo Brambilla, Paolo Brambilla   +5 more
doaj   +3 more sources

Medium- and high-intensity rTMS reduces psychomotor agitation with distinct neurobiologic mechanisms. [PDF]

Transl Psychiatry, 2018
Definitive data are lacking on the mechanism of action and biomarkers of repetitive transcranial magnetic stimulation (rTMS) for the treatment of depression.
Heath A, Lindberg DR, Makowiecki K, Gray A, Asp AJ, Rodger J, Choi DS, Croarkin PE.   +7 more
europepmc   +4 more sources

Management of psychomotor agitation: audit of clinical practice

Journal of Psychology & Clinical Psychiatry, 2020
Background: Psychomotor agitation (PMA) is encountered in different psychiatric settings, with prevalence ranging between 4.3 and 10%. According to The Maudsley Prescribing Guidelines in Psychiatry, stepwise management of PMA starts with behavioral ...
Mustafa Abdul Karim, Yassin El Torki, Inas Felfel, Sali El Hoseny, H. Hashem   +4 more
semanticscholar   +3 more sources

Successful treatment for psychomotor agitation in neuromyelitis optica spectrum disorder with trazodone-risperidone combination: a case report. [PDF]

Neuropsychiatr Dis Treat, 2017
Neuromyelitis optica (NMO) is a relapsing disease that typically affects the spinal cord and optic nerves. So far, a few studies have reported pharmacologic treatment for psychiatric symptoms in patients with NMO spectrum disorder (NMOSD).
Narita Z, Takano H, Sumiyoshi T.
europepmc   +4 more sources